福永 興壱

Medicine & Life Sciences

1. Coronavirus 100%
2. Asthma 70%
3. Lung 63%
4. Japan 52%
5. Pneumonia 42%
6. Eosinophils 40%
7. Chronic Obstructive Pulmonary Disease 40%
8. Inflammation 38%
9. Mycobacterium avium Complex 38%
10. Non-Small Cell Lung Carcinoma 35%
11. SARS Virus 29%
12. Lung Diseases 27%
13. Tomography 26%
14. Lung Neoplasms 26%
15. Acute Lung Injury 24%
16. Therapeutics 24%
17. Advisory Committees 23%
18. Severe Acute Respiratory Syndrome 23%
19. Standing Position 22%
20. Tobacco Products 21%
21. Bronchoalveolar Lavage Fluid 20%
22. Smoke 20%
23. Supine Position 19%
24. Obstructive Sleep Apnea 19%
25. Platelet Activating Factor 19%
26. Serum 18%
27. presqualene pyrophosphate 18%
28. Adenocarcinoma of Lung 18%
29. Adrenal Cortex Hormones 18%
30. Alveolar Epithelial Cells 18%
31. cysteinyl-leukotriene 16%
32. Cyclooxygenase 2 16%
33. prostaglandin D2 receptor 15%
34. Smartphone 15%
35. Multicenter Studies 15%
36. 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid 15%
37. Phenotype 15%
38. Respiratory Function Tests 15%
39. Ovalbumin 14%
40. lipoxin A4 14%
41. Infections 14%
42. pranlukast 14%
43. Lymphocytes 13%
44. Meta-Analysis 13%
45. Lung Injury 13%
46. Smoking Cessation 13%
47. Cytokines 13%
48. Lipopolysaccharides 13%
49. Emphysema 12%
50. Systematic Reviews 12%